Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events

Thrombosis and Haemostasis

Volumn 113, Issue 1, 2015, Pages 85-96

  Campello, Elena ^a   Zabeo, Eva ^a   Radu, Claudia M ^a   Spiezia, Luca ^a   Gavasso, Sabrina ^a   Fadin, Mariangela ^a   Woodhams, Barry ^a,b   Vettor, Roberto ^a   Simioni, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b HaemaCon Ltd   (United Kingdom)

Author keywords

Hypercoagulability; Microparticles; Obesity; Thrombin generation; Tissue factor

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; THROMBOPLASTIN; TRIACYLGLYCEROL; ANTITHROMBIN; AUTACOID; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 7A; THROMBIN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RISK FACTOR; THROMBIN TIME; THROMBOSIS; WAIST CIRCUMFERENCE; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TEST; COMPLICATION; CROSS-SECTIONAL STUDY; METABOLISM; MIDDLE AGED; OVERWEIGHT; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; THROMBOPHILIA;

ADULT; ANTITHROMBINS; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BODY MASS INDEX; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; CROSS-SECTIONAL STUDIES; FACTOR VIIA; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBIN; THROMBOPHILIA; THROMBOPLASTIN; THROMBOSIS; WAIST CIRCUMFERENCE;

EID: 84922366899     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-02-0156     Document Type: Article

References (55)

1. Darvall KAL, Sam RC, Silverman SH, et al. Obesity and thrombosis. Eur J Vasc Endovasc Surg 2007; 33: 223-233.
2. Lorenzet R, Napoleone E, Cutrone A, et al. Thrombosis and obesity: cellular bases. Thromb Res 2012; 129: 285-289.
3. Rosito GA, D’Agostino RB, Massaro J, et al. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost 2004; 91: 683-689.
4. Reaven GM, Scott EM, Grant PJ, et al. Hemostatic abnormalities associated with obesity and the metabolic syndrome. J Thromb Haemost 2005; 3: 1074-1085.
5. Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system. Obes Rev 2002; 3: 85-101.
6. Samad F, Ruf W. Inflammation, obesity, and thrombosis. Blood 2013; 122: 3415-3422.
7. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21: 157-171.
8. Owens III AP, Mackman N. Microparticles in Hemostasis and Thrombosis. Circ Res 2011; 108: 1284-1297.
9. Burger D, Schock S, Thompson CS, et al. Microparticles: biomarkers and beyond. Clin Sci 2013; 124: 423-441.
10. Boulanger CM, Dignat-George F. Microparticles: an introduction. Arterioscler Thromb Vasc Biol 2011; 31: 2-3.
11. Manly DA, Wang J, Glover SL, et al. Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thromb Res 2010; 125: 511-512.
12. Furie B, Furie BC. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 2004; 10: 171-178.
13. Morel O, Toti F, Hugel B, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 2006; 26: 2594-2604.
14. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-949.
15. Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004; 104: 3190-3197.
16. Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin Glycoprotein Ligand 1 and platelet P-selectin. J Exp Med 2003; 197: 1585-1598.
17. Ye R, Ye C, Huang Y, et al. Circulating tissue-factor positive microparticles in patients with acute recurrent deep vein thrombosis. Thromb Res 2012; 130: 253-258.
18. Ay C, Freyssinet JM, Salier T, et al. Circulating procoagulant microparticles in patients with venous thromboembolism. Thromb Res 2009; 123: 724-726.
19. Shantsila E, Kamphuisen PW, Lip GY. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost 2010; 8: 2358-2368.
20. Gross PL, Furie BC, Merrill-Skoloff G, Chou J, Furie B. Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development. J Leukoc Biol 2005; 78: 1318-1326.
21. Suades R, Padró T, Vilahur G, et al. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb Haemost 2012; 108: 1208-1219.
22. Namba M, Tanaka A, Shimada K, et al. Circulating platelet-derived microparticles are associated with atherothrombotic events: a marker for vulnerable blood. Arterioscler Thromb Vasc Biol 2007; 27: 255-256.
23. Goichot B, Grunebaum L, Desprez D, et al. Circulating procoagulant microparticles in obesity. Diabetes Metab 2006; 32: 82-85.
24. Morel O, Luca F, Grunebaum L. Short-term very low-calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles. Int J Obes 2011; 35: 1479-1486.
25. Murakami T, Horigome H, Tanaka K, et al. Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity. Thromb Res 2007; 119: 45-53.
26. Esposito K, Ciotola M, Schisano B, et al. Endothelial microparticles correlate with endothelial dysfunction in obese women. J Clin Endocrinol Metab 2006; 91: 3676-3679.
27. Csongrádi É, Nagy B Jr, Fulop T, et al. Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients. Thromb Haemost 2011; 106: 683-692.
28. Moore XL, Michell D, Lee S, et al. Increased carotid intima-media thickness and reduced distensibility in human class III obesity: independent and differential influences of adiposity and blood pressure on the vasculature. PLoS One 2013; 8: e53972.
29. Helal O, Defoort C, Robert S, et al. Increased levels of Microparticles originating from endothelial cells, platelets and erithrocytes in subjects with metabolic syndrome: relationship with oxidative stress. Nutr Metab Cardiovasc Dis 2011; 21: 665-671.
30. Stepanian A, Bourguignat L, Hennou S, et al. Microparticle increase in severe obesity: not related to metabolic syndrome and unchanged after massive loss. Obesity 2013; 21: 2236-2243.
31. Lacroix R, Dubois C, Leroyer AS, et al. Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost 2013; 11: 24-35.
32. ten Cate H. Thrombin generation in clinical conditions. Thromb Res 2012; 129: 367-370.
33. Spiezia L, Rossetto V, Campello E, et al. Factor VIIa-Antithrombin Complexes in Patients with Arterial and Venous Thrombosis. Thromb Haemost 2010; 103: 1188-1192.
34. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
35. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). J Am Med Assoc 2001; 285: 2486-2497.
36. Koutroumpi S, Spiezia L, Albiger N, et al. Thrombin generation in Cushing’s Syndrome: do the conventional clotting indices tell the whole truth? Pituitary 2014; 17: 68-75.
37. Campello E, Spiezia L, Radu CM, et al. Endothelial, platelet and tissue factorbearing microparticles in cancer patients with and without venous thrombembolism. Thromb Res 2011; 127: 473-477.
38. Campello E, Spiezia L, Radu CM, et al. Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. Thromb Haemost 2012; 108: 633-639.
39. Lacroix R, Robert S, Poncelet P, et al. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2010; 8: 2571-2574.
40. Lacroix R, Judicone C, Mooberry M, et al. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2013; 11: 1190-1193.
41. van Dreden P, Rousseau A, Fontaine S, et al. Clinical evaluation of a new functional test for detection of plasma procoagulant phospholipids. Blood Coag Fibrinolysis 2009; 20: 494-502.
42. Campello E, Spiezia L, Radu CM, et al. Evaluation of a procoagulant phosholipid functional assay as a routine test for measuring circulating microparticle activity. Blood Coagul Fibrinolysis 2014; 25: 534-537.
43. De Pergola G, Pannacciulli N. Coagulation and fibrinolyses abnomalities in obesity. J Endocrinol Invest 2002; 25: 899-904.
44. Cimenti C, Mangge H, Haidl H, et al. Thrombin generation in severely obese children. J Thromb Haemost 2006; 4: 1834-1836.
45. Chen M, Geng JG. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp 2006; 54: 75-84.
46. Khew-Goodall Y, Butcher CM, Litwin MS, et al. Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin-3. Blood 1996; 87: 1432-1438.
47. Schafer K, Konstantinides S. Adipokines and thrombosis. Clin Exp Pharmacol Physiol 2011; 38: 864-871.
48. Prüller F, Raggam RB, Posch V, et al. Trunk weighted obesity, cholesterol levels and low grade inflammation are main determinants for enhanced thrombin generation. Atherosclerosis 2012; 220: 215-218.
49. Badimon L, Storey RF, Vilahur G. Update on lipids, inflammation and atherothrombosis. Thromb Haemost 2011; 105: S34-S42.
50. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011; 29: 415-445.
51. Zhang X, McGeoch SC, Johnstone AM, et al. Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status. J Thromb Thrombolysis 2014; 37:455-463.
52. Tian YF, Chang WC, Loh CH, Hsieh PS. Leptin-mediated inflammatory signaling crucially links visceral fat inflammation to obesity-associated_-cell dysfunction. Life Sci 2014; Epub ahead of print.
53. Sanchez C, Poggi M, Morange PE, et al. Diet modulates endogenous thrombin generation, a biological estimate of thrombosis risk, independently of the metabolic status. Arterioscler Thromb Vasc Biol 2012; 32: 2394-2404.
54. Gheldof D, Hardij J, Cecchet F, et al. Thrombin generation assay and transmission electron microscopy: a useful combination to study tissue factor-bearing microvesicles. J Extracell Vesicles 2013; 2: 19728.
55. Connor DE, Exner T, Ma DD, et al. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010; 103: 1044-1052.